World Drug Discovery Technologies Market - Opportunities and Forecasts, 2014 -2022
|
A01160
|
Pages: NA
|
May 2020 |
1978 Views
|
|
|
|
Author(s) :
NA
|
Tables: NA
|
Charts: NA
|
Formats*:
|
|
Drug discovery is the process by which new medications are discovered. It uses vast array of technologies in the process. Drug discovery technologies are used for the research and the launch of new drugs. Increased use of therapeutics in various diseases has created the need for drug discovery. Recently, with the development of technology, many new types of techniques such as nanotechnology and RNA interference are being used for the purpose of drug discovery. This has created the opportunities for drug discovery technology manufacturers in the new segments. The increasing incidences of diseases, patent expiries, pathogen resistance to old drugs and fierce competition among drug manufacturers are the key factors, which would drive the growth of drug discovery technologies market during the analysis period. Furthermore, in order to earn additional margins, the pharmaceutical companies are in pursuit of blockbuster drugs, which has increased the demand for drug discovery technologies. Factors restraining the market growth are long duration of drug discovery process, high initial setup cost and presence of stringent regulatory environment.
The global drug discovery market is segmented on the basis of technology type, application and geography. The technology types considered in this report are high throughput screening, genomics, biochips, pharmacogenomics, bioanalytical instruments, bioinformatics, nanotechnology and others (RNAi, combinatorial chemistry). Based on end user, the global drug discovery market is classified into pharmaceutical companies, biopharmaceutical companies, biotech companies and research institutes. Geographically, the report is segmented into four regions viz., North America, Europe, Asia-Pacific and LAMEA. One of the strategies adopted by major market players is collaboration. For instance, in 2015, Myriad Genetics collaborated with Abbott Laboratories. The companies profiled in this report are Abbott Laboratories, Albany Molecular Research, Arqule, Bio-Rad Laboratories, Caliper Life Sciences, Celera Corp, Charles River Laboratories International, Evotec Ag, Gyros AbIncyte Corp and Thermo Fisher Scientific Inc.
KEY MARKET BENEFITS:
- The report provides a quantitative analysis of the current market and estimations through 2014-2020, which would enable the stakeholders to capitalize on prevailing market opportunities
- Extensive analysis of the global apheresis equipment market by product type helps in understanding the types of equipment that are currently used along with the variants that would gain prominence in future
- Competitive intelligence highlights the business practices followed by leading market players across various geographies
- Comprehensive analysis of factors that drive and restrict the growth of the global apheresis equipment market is provided
- SWOT analysis highlights the internal environment of leading companies for effective strategy formulation
- The apheresis equipment market scenario is comprehensively analysed in accordance to the key regions
KEY MARKET SEGMENTS:
The global drug discovery technologies market is segmented as below:
Global Drug Discovery Technologies Market By Technology Type
- High throughput screening
- Genomics
- Biochips
- Pharmacogenomics
- Bioanalytical instruments
- Bioinformatics
- Nanotechnology
- Others (RNAi, combinatorial chemistry)
Global Drug Discovery Technologies Market By End User
- Pharmaceutical companies
- Biopharmaceutical companies
- Biotech companies
- Research institutes
Global Drug Discovery Technologies Market By Geography
- North America
- Europe
- Asia-Pacific
- LAMEA
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. TOP PLAYER POSITIONING/MARKET SHARE ANALYSIS, 2016
3.4. MARKET DYNAMICS
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
3.5. CURRENT DISRUPTIVE TECHNOLOGIES
CHAPTER 4 DRUG DISCOVERY TECHNOLOGIES MARKET, BY TECHNOLOGY
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. HIGH THROUGHPUT SCREENING (HTS)
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.3. GENOMICS
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.4. BIOCHIPS
4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast
4.5. BIOANALYTICAL INSTRUMENTS
4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size and forecast
4.6. BIOINFORMATICS
4.6.1. Key market trends
4.6.2. Growth factors and opportunities
4.6.3. Market size and forecast
4.7. PROTEOMICS
4.7.1. Key market trends
4.7.2. Growth factors and opportunities
4.7.3. Market size and forecast
4.8. NANOTECHNOLOGY
4.8.1. Key market trends
4.8.2. Growth factors and opportunities
4.8.3. Market size and forecast
4.9. OTHER TECHNOLOGIES
4.9.1. Key market trends
4.9.2. Growth factors and opportunities
4.9.3. Market size and forecast
CHAPTER 5 DRUG DISCOVERY TECHNOLOGIES, BY APPLICATION
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. CANCER
5.2.1. Market size and forecast
5.3. CARDIOVASCULAR DISEASES
5.3.1. Market size and forecast
5.4. CENTRAL NERVOUS SYSTEM DISORDERS
5.4.1. Market size and forecast
5.5. OTHER APPLICATIONS
5.5.1. Market size and forecast
CHAPTER 6 DRUG DISCOVERY TECHNOLOGIES, BY END USER
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. PHARMACEUTICAL COMPANIES
6.2.1. Market size and forecast
6.3. BIOPHARMACEUTICAL COMPANIES
6.3.1. Market size and forecast
6.4. BIOTECH COMPANIES
6.4.1. Market size and forecast
6.5. RESEARCH INSTITUTES
6.5.1. Market size and forecast
6.6. OTHER END USER
6.6.1. Market size and forecast
CHAPTER 7 DRUG DISCOVERY TECHNOLOGIES, BY REGION
7.1. OVERVIEW
7.2. NORTH AMERICA
7.2.1. Key market trends
7.2.2. Key growth factors and opportunities
7.2.3. North America Drug Discovery Technologies Market, by Country
7.2.3.1. Market size and forecast
7.2.3.2. U.S.
7.2.3.2.1. U.S. Drug Discovery Technologies Market, by Technology
7.2.3.2.2. U.S. Drug Discovery Technologies Market, by Application
7.2.3.2.3. U.S. Drug Discovery Technologies Market, by End User
7.2.3.3. Canada
7.2.3.3.1. Canada Drug Discovery Technologies Market, by Technology
7.2.3.3.2. Canada Drug Discovery Technologies Market, by Application
7.2.3.3.3. Canada Drug Discovery Technologies Market, by End User
7.2.3.4. Mexico
7.2.3.4.1. Mexico Drug Discovery Technologies Market, by Technology
7.2.3.4.2. Mexico Drug Discovery Technologies Market, by Application
7.2.3.4.3. Mexico Drug Discovery Technologies Market, by End User
7.2.4. North America Drug Discovery Technologies Market, by Technology
7.2.5. North America Drug Discovery Technologies Market, by Application
7.2.6. North America Drug Discovery Technologies Market, by End User
7.3. EUROPE
7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Europe Drug Discovery Technologies Market, by Country
7.3.3.1. Market size and forecast
7.3.3.2. Germany
7.3.3.2.1. Germany Drug Discovery Technologies Market, by Technology
7.3.3.2.2. Germany Drug Discovery Technologies Market, by Application
7.3.3.2.3. Germany Drug Discovery Technologies Market, by End User
7.3.3.3. France
7.3.3.3.1. France Drug Discovery Technologies Market, by Technology
7.3.3.3.2. France Drug Discovery Technologies Market, by Application
7.3.3.3.3. France Drug Discovery Technologies Market, by End User
7.3.3.4. UK
7.3.3.4.1. UK Drug Discovery Technologies Market, by Technology
7.3.3.4.2. UK Drug Discovery Technologies Market, by Application
7.3.3.4.3. UK Drug Discovery Technologies Market, by End User
7.3.3.5. Italy
7.3.3.5.1. Italy Drug Discovery Technologies Market, by Technology
7.3.3.5.2. Italy Drug Discovery Technologies Market, by Application
7.3.3.5.3. Italy Drug Discovery Technologies Market, by End User
7.3.3.6. Spain
7.3.3.6.1. Spain Drug Discovery Technologies Market, by Technology
7.3.3.6.2. Spain Drug Discovery Technologies Market, by Application
7.3.3.6.3. Spain Drug Discovery Technologies Market, by End User
7.3.3.7. Rest of Europe
7.3.3.7.1. Rest of Europe Drug Discovery Technologies Market, by Technology
7.3.3.7.2. Rest of Europe Drug Discovery Technologies Market, by Application
7.3.3.7.3. Rest of Europe Drug Discovery Technologies Market, by End User
7.3.4. Europe Drug Discovery Technologies Market, by Technology
7.3.5. Europe Drug Discovery Technologies Market, by Application
7.3.6. Europe Drug Discovery Technologies Market, by End User
7.4. ASIA-PACIFIC
7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Asia-Pacific Drug Discovery Technologies Market, by Country
7.4.3.1. Market size and forecast
7.4.3.2. Japan
7.4.3.2.1. Japan Drug Discovery Technologies Market, by Technology
7.4.3.2.2. Japan Drug Discovery Technologies Market, by Application
7.4.3.2.3. Japan Drug Discovery Technologies Market, by End User
7.4.3.3. China
7.4.3.3.1. China Drug Discovery Technologies Market, by Technology
7.4.3.3.2. China Drug Discovery Technologies Market, by Application
7.4.3.3.3. China Drug Discovery Technologies Market, by End User
7.4.3.4. Australia
7.4.3.4.1. Australia Drug Discovery Technologies Market, by Technology
7.4.3.4.2. Australia Drug Discovery Technologies Market, by Application
7.4.3.4.3. Australia Drug Discovery Technologies Market, by End User
7.4.3.5. India
7.4.3.5.1. India Drug Discovery Technologies Market, by Technology
7.4.3.5.2. India Drug Discovery Technologies Market, by Application
7.4.3.5.3. India Drug Discovery Technologies Market, by End User
7.4.3.6. South Korea
7.4.3.6.1. South Korea Drug Discovery Technologies Market, by Technology
7.4.3.6.2. South Korea Drug Discovery Technologies Market, by Application
7.4.3.6.3. South Korea Drug Discovery Technologies Market, by End User
7.4.3.7. Rest of Asia-Pacific
7.4.3.7.1. Rest of Asia-Pacific Drug Discovery Technologies Market, by Technology
7.4.3.7.2. Rest of Asia-Pacific Drug Discovery Technologies Market, by Application
7.4.3.7.3. Rest of Asia-Pacific Drug Discovery Technologies Market, by End User
7.4.4. Asia-Pacific Drug Discovery Technologies Market, by Technology
7.4.5. Asia-Pacific Drug Discovery Technologies Market, by Application
7.4.6. Asia-Pacific Drug Discovery Technologies Market, by End User
7.5. LAMEA
7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. LAMEA Drug Discovery Technologies Market, by Country
7.5.3.1. Market size and forecast
7.5.3.2. Brazil
7.5.3.2.1. Brazil Drug Discovery Technologies Market, by Technology
7.5.3.2.2. Brazil Drug Discovery Technologies Market, by Application
7.5.3.2.3. Brazil Drug Discovery Technologies Market, by End User
7.5.3.3. Saudi Arabia
7.5.3.3.1. Saudi Arabia Drug Discovery Technologies Market, by Technology
7.5.3.3.2. Saudi Arabia Drug Discovery Technologies Market, by Application
7.5.3.3.3. Saudi Arabia Drug Discovery Technologies Market, by End User
7.5.3.4. South Africa
7.5.3.4.1. South Africa Drug Discovery Technologies Market, by Technology
7.5.3.4.2. South Africa Drug Discovery Technologies Market, by Application
7.5.3.4.3. South Africa Drug Discovery Technologies Market, by End User
7.5.3.5. Rest of LAMEA
7.5.3.5.1. Rest of LAMEA Drug Discovery Technologies Market, by Technology
7.5.3.5.2. Rest of LAMEA Drug Discovery Technologies Market, by Application
7.5.3.5.3. Rest of LAMEA Drug Discovery Technologies Market, by End User
7.5.4. LAMEA Drug Discovery Technologies Market, by Technology
7.5.5. LAMEA Drug Discovery Technologies Market, by Application
7.5.6. LAMEA Drug Discovery Technologies Market, by End User
CHAPTER 8 COMPANY PROFILES
8.1. ABBOTT LABORATORIES
8.1.1. Operating business segments
8.1.2. Business performance
8.1.3. Key strategic moves and developments
8.2. ALBANY MOLECULAR RESEARCH INC. (AMRI)
8.2.1. Operating business segments
8.2.2. Business performance
8.2.3. Key strategic moves and developments
8.3. ARQULE, INC.
8.3.1. Operating business segments
8.3.2. Business performance
8.3.3. Key strategic moves and developments
8.4. BIO-RAD LABORATORIES, INC.
8.4.1. Operating business segments
8.4.2. Business performance
8.4.3. Key strategic moves and developments
8.5. CALIPER LIFE SCIENCES (PERKINELMER INC.)
8.5.1. Operating business segments
8.5.2. Business performance
8.5.3. Key strategic moves and developments
8.6. CELERA CORPORATION
8.6.1. Operating business segments
8.6.2. Business performance
8.6.3. Key strategic moves and developments
8.7. CHARLES RIVER LABORATORIES, INC.
8.7.1. Operating business segments
8.7.2. Business performance
8.7.3. Key strategic moves and developments
8.8. EVOTEC A.G.
8.8.1. Operating business segments
8.8.2. Business performance
8.8.3. Key strategic moves and developments
8.9. F. HOFFMANN-LA ROCHE AG
8.9.1. Operating business segments
8.9.2. Business performance
8.9.3. Key strategic moves and developments
8.10. THERMO FISHER SCIENTIFIC
8.10.1. Operating business segments
8.10.2. Business performance
8.10.3. Key strategic moves and developments
We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:
- Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
- Technologically sophisticated and reliable insights through well audited and veracious research methodology
- Sovereign research proceeds that present a tangible depiction of marketplace
With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.
Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, web-casts and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast
Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develops analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth and forecasts
Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:
- Chief executives and VPs of leading corporations specific to industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)
Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
REQUEST TOC/SAMPLE
Purchase Full Report of
World Drug Discovery Technologies Market-
Opportunities and Forecasts, 2014 -2022
- Online Only
-
$3,456$3,110 - Online cloud access only
- Restricted print, copy, paste & download
- Read only
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Data Pack
-
$3,840$3,456 - Restricted to one authorized user
- One print only
- Available in
Excel - Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Single User
-
$5,370$4,833 - Restricted to one authorized user
- One print only
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Five Users
-
$6,450$5,805 - Limited to five authorized users
- Print upto five copies
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
-
Enterprise
License/PDF -
$8,995$8,096 - Unlimited
within
company/enterprise - Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Library Membership
- $0.00
- Published Content
E-access - Company Profiles
E-access - Newly Added Content Access
- 10 PDF
Downloads - 5 Excel Data
Pack Downloads - 250 Company Profiles PDF Downloads
-
Start reading.
Buy Now
This title and over 12,000+ are available on the Avenue Library. Subscription @ $699 T&C*.
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
Why Allied Market Research?
Infallible Methodology
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
Analyst Support
For complete satisfaction
Customization
On-demand customization of scope of the report to exactly meet your needs
TARGETED MARKET VIEW
Targeted market view to provide pertinent information and save time of readers
Get fresh content delivered
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.